抗癌免疫中的循环节律:机制和治疗机会
Robert Pick1, Chen Wang1, Qun Zeng1
1Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; email: robert.pick@unige.ch, chen_wang@dfci.harvard.edu, qun.zeng@unige.ch, zeynep.guel@unige.ch, christoph.scheiermann@unige.ch.
Annual review of immunology
|June 28, 2024
概括
昼夜节律显著影响免疫反应,包括抗瘤免疫. 通过慢性免疫疗法利用这些生物节奏,为优化癌症治疗提供了一个有前途的战略.
科学领域:
- 免疫学 免疫学 免疫学
- 时间生物学 时间生物学
- 癌症研究 癌症研究
背景情况:
- 循环节律 (大约24小时周期) 越来越多地被认为是先天和适应性免疫反应的关键调节者.
- 新出现的证据凸显了昼夜节律在调节前临床模型和人类患者的抗瘤免疫力方面的关键作用.
研究的目的:
- 审查关于昼夜节律对抗瘤免疫反应的影响的当前文献.
- 阐明控制这些昼夜免疫振荡的基本机制.
- 为提供对利用时间依赖的免疫变异以提高疗效的慢性免疫疗法的概述.
主要方法:
- 对调查昼夜节律和免疫力的研究进行文献综述.
- 分析免疫反应的昼夜控制背后的机制.
- 编制关于时间免疫治疗策略的数据.
主要成果:
- 循环节律影响免疫反应对瘤的启动和有效性.
- 特定的分子和细胞机制将昼夜时间与免疫细胞功能和瘤监测联系起来.
- 慢性免疫疗法通过将治疗干预与免疫系统振荡相协调,显示出改善治疗结果的潜力.
结论:
- 了解昼夜免疫系统对于推进癌症治疗至关重要.
- 慢性免疫疗法代表了一种新的治疗范式,有可能彻底改变癌症和其他疾病的治疗.
- 对昼夜免疫学的进一步研究可以改善临床实践和患者的治疗结果.
相关概念视频
Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
351
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
351
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K


